Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.02%
#3 CoW Protocol CoW Protocol +39.55%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +25.07%
#6 Walrus Walrus +22.69%
#7 Enso Enso +21.93%
#8 Tutorial Tutorial +17.35%
#9 Codatta Codatta +16.76%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
EXOD EXOD
Настройки
Язык
Pусский
Валюта
USD
Тема
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Ранг среди акций #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Цена акции
$0.6
Последняя синхронизация: 2024-08-14
Рыночная капитализация
$2.09M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
SG
Торговля ASLAN Pharmaceuticals Limited (ASLN)

Категория

Healthcare
Коэффициент P/B для ASLAN Pharmaceuticals Limited (ASLN)
Коэффициент P/B на August 2026 TTM: -0.19
Согласно последним финансовым отчетам и цене акций ASLAN Pharmaceuticals Limited, текущий коэффициент P/B (TTM) составляет -0.19. В конце 2022 он составлял 0.96.
История P/B для ASLAN Pharmaceuticals Limited с 2014 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) -0.19 -11.57%
2023 -0.21 -121.55%
2022 0.96 135.76%
2021 0.41 -118.92%
2020 -2.15 -82.88%
2019 -12.58 -1,216.28%
2018 1.13 -10.51%
2017 1.26 11.69%
2016 1.13 -308.68%
2015 -0.54 496.91%
2014 -0.09 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -3,515.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -3,460.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -1,963.87%
BE